#USA #Vienna #AAV8 #PAK BioSolutions #iBET

PAK BioSolutions and iBET's Breakthrough in AAV8 Purification

PAK BioSolutions has made headlines with the recent publication of a peer-reviewed study focusing on the integrated, continuous purification process of adeno-associated virus serotype 8 (AAV8). This remarkable study, conducted in partnership with iBET – Instituto de Biologia Experimental e Tecnológica, was featured in the journal Separation and Purification Technology. The research team has successfully developed a purification protocol that demonstrates effective performance across multiple cycles while achieving key metrics of product quality.

Key Findings of the Study

The study’s focused efforts on creating a cyclic capture and polishing process operated seamlessly for a marathon of 12 hours. Throughout this operational journey, the process showcased reproducible and stable results with every cycle conducted. Notably, the final product pools resulted in an impressive 79% full-capsid enrichment, a significant milestone for the manufacturing of viral vectors essential for gene therapies. The researchers are optimistic that these advancements can revolutionize the field of biopharmaceutical production as AAV vectors remain pivotal in the development of in vivo gene therapy treatments.

Why Continuous Downstream Processing is Pivotal

With clinical interventions based on AAV vectors becoming increasingly mainstream, rising demands for throughput and product quality pose a challenge. Traditional batch processing workflows had limitations that could hinder the efficiency of gene therapy manufacturing. Continuous downstream processing combines the benefits of efficiency while enhancing product quality. Historically, advancements in this method have been stunted, often isolating purification steps instead of integrating them effectively.

Merging Capture and Polishing Processes

In an innovative take, the researchers merged two vital components of the purification process into one cohesive operation. By utilizing AAVX affinity capture paired with Mustang® Q anion-exchange membrane polishing, the study effectively coordinated two alternating columns. During purification, while one column engaged in the loading phase, the other would be in the elution and regeneration phase. This intelligent column switching and automation facilitated simultaneous operation of capture and polishing processes, setting a new precedent in purification methodologies.

Joanna Pezzini, CEO of PAK BioSolutions, expressed enthusiasm for this breakthrough, remarking, "This study offers a dynamic approach for AAV purification, supporting manufacturers in adopting more efficient production strategies."

Overview of Results

The study's results clearly affirm the efficacy of this integrated model:

• - Full-Capsid Enrichment: The process enhanced full-capsid enrichment from a starting point of 34% post-affinity capture to a notable 79% in the final polished outputs.
• - Vector Genome Recovery: The recovery rates were equally impressive, with a 44% retention of vector genomes achieved from the feeding input to the final product.
• - Impurity Reduction: Both double-stranded DNA levels and host cell protein levels were effectively reduced to below detectable limits, contributing to the high purity of the final product.

The purity attained within this continuous process aligns well with benchmarks set by existing batch workflows, further encouraging the migration toward integrated systems for better results.

Conclusion

As advancements in gene therapy continue to skyrocket, the ability to translate traditional purification processes into integrated continuous formats remains a game-changer for the industry. PAK BioSolutions and iBET's study highlights the potential of continuous operations not only to streamline but also to enhance the quality of AAV8 purification, enabling manufacturers to meet increasing demands and push the boundaries of biopharmaceutical innovation. The study stands as a testament to the unyielding pursuit of excellence in the industry, marking a significant leap towards a more efficient future.

Learn More

For additional details regarding the PAK PD™ Process Development Scale Continuous Purification System and its capabilities, please visit PAK BioSolutions.